Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Parker, Daniel ^a   Lerdprom, Rujira ^b   Srisatjarak, Wanna ^b   Yan, Guiyun ^c   Sattabongkot, Jetsumon ^d   Wood, James ^a   Sirichaisinthop, Jeeraphat ^b   Cui, Liwang ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Vector Borne Disease Training Center   (Thailand)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Artemisinin; Drug resistance; Mefloquine; Plasmodium falciparum; Thailand; The Greater Mekong subregion

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; DIHYDROARTEMISININ; HISTIDINE; MEFLOQUINE; QUININE;

ARTICLE; BLOOD ANALYSIS; CAMBODIA; CLINICAL PROTOCOL; DRUG SENSITIVITY; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; LAOS; LONGITUDINAL STUDY; MALARIA; MALAYSIA; NONHUMAN; PARASITE; PLASMODIUM FALCIPARUM; POLICY; THAILAND; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; ANTIMALARIALS; HUMANS; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; THAILAND;

EID: 84865074083     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-290     Document Type: Article

References (38)

1. Epidemiology of drug resistance in malaria. Wernsdorfer WH, Acta Trop 1994 56 143 156 10.1016/0001-706X(94)90060-4 8203301
2. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Singhasivanon P, Southeast Asian J Trop Med Public Health 1999 30 Suppl 4 iv 1-101 10935286
3. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Wongsrichanalai C, Sirichaisinthop J, Karwacki JJ, Congpuong K, Miller RS, Pang L, Thimasarn K, Southeast Asian J Trop Med Public Health 2001 32 41 49 11485094
4. Artemisinin-based combination treatment of falciparum malaria. Nosten F, White NJ, Am J Trop Med Hyg 2007 77 181 192 18165491
5. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
6. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Maung Lwin K, Pyae Phyo A, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F, PLoS One 2009 4 4551 10.1371/journal.pone. 0004551 19234601
7. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phae Phyo A, Tarning J, Maung Lwin K, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, Sam An S, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
8. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Pyae Phyo A, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Maung Lwin K, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F, Lancet 2012 12 1960 1966
9. A major genome region underlying artemisinin resistance in malaria. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Pyae Phyo A, Ler Moo C, Maung Lwin K, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJC, Science 2012 336 79 82 10.1126/science.1215966 22491853
10. Fake artesunate in southeast Asia. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, Chotivanich K, Mayxay M, Looareesuwan S, Farrar J, Nosten F, White NJ, Lancet 2001 357 1948 1950 10.1016/S0140-6736(00)05085-6 11425421
11. How do patients use antimalarial drugs? A review of the evidence. Yeung S, White NJ, Trop Med Int Health 2005 10 121 138 10.1111/j.1365-3156.2004.01364. x 15679555
12. The origins and spread of antimalarial drug resistance: lessons for policy makers. Anderson TJ, Roper C, Acta Trop 2005 94 269 280 10.1016/j.actatropica.2005.04.010 15878153
13. WHO, In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine sulfadoxine/pyrimethamine and artemisinin. Instruction for use of the in vitro microtest kit (Mark III) Geneva: World Health Organization 2001
14. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS, Am J Trop Med Hyg 2004 71 711 714 15642959
15. Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand. Suebsaeng L, Wernsdorfer WH, Rooney W, Bull World Health Organ 1986 64 759 765 3542267
16. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Bjorkman A, Am J Trop Med Hyg 2003 68 413 415 12875289
17. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mita T, Kaneko A, Lum JK, Zungu IL, Tsukahara T, Eto H, Kobayakawa T, Bjorkman A, Tanabe K, Mol Biochem Parasitol 2004 135 159 163 10.1016/j.molbiopara.2004.01.011 15287598
18. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Wang X, Mu J, Li G, Chen P, Guo X, Fu L, Chen L, Su X, Wellems TE, Am J Trop Med Hyg 2005 72 410 414 15827277
19. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Snounou G, White NJ, Trends Parasitol 2004 20 333 339 10.1016/j.pt.2004.05.004 15193565
20. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Brockman A, Price RN, van Vugt M, Heppner DG, Walsh D, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2000 94 537 544 10.1016/S0035-9203(00)90080-4 11132385
21. Effects of artesunate-mefloquine combination on incidence ofPlasmodium falciparummalaria and mefloquine resistance in Western Thailand: a prospective study. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
22. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Na-Bangchang K, Ruengweerayut R, Mahamad P, Ruengweerayut K, Chaijaroenkul W, Malar J 2010 9 273 10.1186/1475-2875-9-273 20929590
23. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Sidhu AB, Valderramos SG, Fidock DA, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034
24. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K, Acta Trop 2010 113 190 194 10.1016/j.actatropica.2009.10.016 19879850
25. Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum. Poyomtip T, Suwandittakul N, Sitthichot N, Khositnithikul R, Tan-Ariya P, Mungthin M, Malar J 2012 11 7 10.1186/1475-2875-11-7 22221394
26. Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping. Liu S, Mu J, Jiang H, Su XZ, Am J Trop Med Hyg 2008 79 178 184 18689621
27. Bloland PB, Drug resistance in malaria Geneva: World Health Organization 2001 WHO/CDS/CSR/DRS/20014
28. Vivax malaria: neglected and not benign. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, Am J Trop Med Hyg 2007 77 79 87 18165478
29. Severe and fatal vivax malaria challenges 'benign tertian malaria' dogma. Baird JK, Ann Trop Paediatr 2009 29 251 252 10.1179/027249309X12547917868808 19941746
30. Benign tertian malaria-a misnomer? Bammigatti C, Shetty S, Shetty S, Kumar A, Trop Doct 2011 41 168 169 10.1258/td.2011.110025 21676982
31. In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from Central China. Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, Cui L, Sattabongkot J, Am J Trop Med Hyg 2011 85 197 201 10.4269/ajtmh.2011.10- 0070 21813834
32. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010. Muhamad P, Ruengweerayut R, Chacharoenkul W, Rungsihirunrat K, Na-Bangchang K, Malar J 2011 10 44 10.1186/1475-2875-10-44 21324161
33. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Myat Phone K, Myint O, Myint L, Thaw Z, Kyin Hla A, Nwe Nwe Y, Trans R Soc Trop Med Hyg 1993 87 687 10.1016/0035-9203(93)90294-Z 8296378
34. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Marlar T, Myat Phone K, Aye Yu S, Khaing Khaing G, Ma S, Myint O, Trans R Soc Trop Med Hyg 1995 89 307 308 10.1016/0035-9203(95)90556-1 7660445
35. Plasmodium vivaxresistance to chloroquine in Dawei, Southern Myanmar. Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, Min Lwin M, Zaw T, Annerberg A, de Radigues X, Nosten F, Trop Med Int Health 2008 13 91 10.1111/j.1365-3156.2007.01978.x 18291007
36. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010. Congpoung K, Satimai W, Sujariyakul A, Intanakom S, Harnpitakpong W, Pranuth Y, Cholpol S, Bualombai P, J Vector Borne Dis 2011 48 190 196 22297279
37. Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand. Rijken MJ, Boel ME, Russell B, Imwong M, Leimanis ML, Phyo AP, Muehlenbachs A, Lindegardh N, McGready R, Renia L, Snounou G, Singhasivanon P, Nosten F, Malar J 2011 10 113 10.1186/1475-2875-10-113 21545737
38. Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Phyo AP, Lwin KM, Price RN, Ashley EA, Russell B, Sriprawat K, Lindegardh N, Singhasivanon P, White NJ, Nosten F, Clin Infect Dis 2011 53 977 984 10.1093/cid/cir631 22002979